Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 13, 2010

Primary Completion Date

April 12, 2012

Study Completion Date

June 26, 2012

Conditions

Leukaemia, Lymphocytic, Chronic

Interventions

BIOLOGICAL

Ofatumumab

Anti-CD20 monoclonal antibody

Trial Locations (4)

GSK Investigational Site, Auckland

GSK Investigational Site, Randwick

GSK Investigational Site, Christchurch

GSK Investigational Site, La Jolla